Ads
related to: placebo
Search results
Insmed shares double as lung drug data convince Wall Street
BioPharma Dive via Yahoo Finance· 6 hours agoAfter reporting positive clinical trial results for its drug brensocatib, Insmed plans to later this...
Why Is Inflammatory Diseased-Focused Insmed Stock Soaring On Tuesday?
Benzinga via Yahoo Finance· 3 hours agoInsmed Incorporated (NASDAQ:INSM) shares are trading higher after the company released topline...
Drug shows promise for getting people to quit vaping
Futurity· 5 hours agoThe results of the study, published in the American Journal of Preventive Medicine, showed a significant disparity between the placebo group and the...
Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing...
KSAN - KLST San Angelo· 3 days agoPatients treated with Fabhalta in addition to supportive care achieved a 35.1% (p=0.0014) reduction in proteinuria (as measured by 24-hour urine protein to creatinine ratio [UPCR]) at 6 months ...
Psychostimulant No Help in Relieving Cancer-Related Fatigue
MedPage Today· 7 days agoThe psychostimulant methylphenidate proved no better than placebo for relieving cancer-related...
This Is the Best Time of Day To Eat Protein, According to a Dietitian
Health.com· 11 hours agoProtein is composed of amino acids, which are needed for important processes such as immune...
Insmed shares rise on positive phase 3 trial results By Investing.com
Investing.com· 6 hours agoOn Tuesday, Insmed (NASDAQ:INSM) Incorporated (NASDAQ:INSM) received a reiterated Buy rating and a...
Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major...
Digital Journal· 6 hours agoThe mean reduction was 13.90 in the placebo group, 15.61 in the 10 mg group and 16.94 in the 20 mg group. A clear dose response and a clinically meaningful, but not statistically ...
Why Is Insmed (INSM) Stock Up 134% Today?
InvestorPlace· 6 hours agoInsmed (NASDAQ:INSM) stock is rising higher on Tuesday after the company announced positive results from a Phase 3 clinical trial of brensocatib in...
Dupilumab Improves Outcomes in COPD With Type 2 Inflammation
Medscape· 13 hours agoNew trial confirmed safety and efficacy of a subcutaneous add-on therapy for uncontrolled COPD.
